Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PRKCG | P05129 | 1/20 | 0.38 |
| ▸ | PRKCB | P05771 | 1/20 | 0.38 |
| ▸ | PRKCA | P17252 | 1/20 | 0.38 |
| ▸ | PRKCH | P24723 | 1/20 | 0.38 |
| ▸ | PRKCI | P41743 | 1/20 | 0.38 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.38 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.38 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.38 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.35 |
| ▸ | ADH1C | P00326 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199182 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL101659 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL102106 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL199151 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL5090198 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL99895 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL102766 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL201848 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL201353 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 | |
| SCHEMBL11289246 | 0.97 | ACE2 (0.52) | ACE2OPRM1LMNASPHK1PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1753708-B1 | NOVEL SIRTUIN ACTIVATING COMPOUNDS AND METHODS FOR MAKING THE SAME | UNIV BRIGHAM YOUNG (US) | 2018-02-21 | — | — | EP | claimed |
| US-8410161-B2 | Thioxanthone ring system derivatives | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2013-04-02 | — | — | US | claimed |
| US-20120088810-A1 | THIOXANTHONE RING SYSTEM DERIVATIVES | NATIONAL DEFENSE MEDICAL CENTER (TW) | 2012-04-12 | — | — | US | claimed |
| WO-2024147345-A1 | COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES, NEGATIVE ELECTRODE FOR LITHIUM ION BATTERIES, LITHIUM ION BATTERY, AND METHOD FOR PRODUCING COATED NEGATIVE ELECTRODE ACTIVE MATERIAL PARTICLES FOR LITHIUM ION BATTERIES | ＡＰＢ株式会社 | 2024-07-11 | — | — | WO | disclosed |
| CN-115232184-B | Ribofuranosylpyridine derivatives, pharmaceutical compositions and uses thereof | 宁波熙健医药科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| US-20240191009-A1 | POLYFUNCTIONALIZED HIGH-CIS 1,4-POLYBUTADIENE AND METHOD FOR MANUFACTURING THE SAME | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2024-06-13 | — | — | US | disclosed |
| US-20240182746-A1 | POLYMER COMPOSITION COMPRISING POLYACRYLIC BLOCK COPOLYMER AND AROMATIC BASED POLYALKYLENEOXIDE AS DISPERSANT | BASF SE (DE) | 2024-06-06 | — | — | US | disclosed |
| CN-118139909-A | Beta-methyl-delta-valerolactone based polymer | 株式会社可乐丽 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139926-A | Resin composition | 株式会社可乐丽 | 2024-06-04 | — | — | CN | disclosed |
| CN-111372916-B | Process for producing dipyrrolidine compounds | 巴斯夫欧洲公司 | 2024-03-26 | — | — | CN | disclosed |
| US-4122282-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-10-24 | — | — | US | disclosed |
| US-4099014-A | BLOOD PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4092469-A | OF CONJUGATED DIENES, BIS(1,3-DIENYL)DIALKYL TIN, LEAD, OR GERMANIUM | PHILLIPS PETROLEUM COMPANY (US) | 1978-05-30 | — | — | US | disclosed |
| US-4085139-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
| US-4081478-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-03-28 | — | — | US | disclosed |
| US-4073808-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1978-02-14 | — | — | US | disclosed |
| US-4041227-A | USING BIS(1,3-DIENYL)DIALKYLTIN, -LEAD, OR -GERMANIUM IN THE POLYMERIZATION OF CONJUGATED DIENE POLYMERS | PHILLIPS PETROLEUM COMPANY (US) | 1977-08-09 | — | — | US | disclosed |
| US-4033989-A | 9-Deoxy-PGF2 Analogs | THE UPJOHN COMPANY (US) | 1977-07-05 | — | — | US | disclosed |
| US-4016184-A | PROSTAGLANDINS, BLOOD PLATELET AGGREGATION INHIBITORS | THE UPJOHN COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088810-A1 | THIOXANTHONE RING SYSTEM DERIVATIVES | TST, TXN, XDH | ACE2 2405/4885OPRM1 930/4885LMNA 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.